Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV)

VERTIS-CV Investigators

Research output: Contribution to journalArticlepeer-review

147 Scopus citations

Fingerprint

Dive into the research topics of 'Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV)'. Together they form a unique fingerprint.

Medicine & Life Sciences